Table 6.
Efficacy of stereotactic body radiotherapy (SBRT) for locally advanced pancreatic cancer (PC).
| Reference | Design | No. of Patients | Median Dose (Gy) | Fractions | Median FU (Months) | Local Control (%) |
Median OS (Months) |
|---|---|---|---|---|---|---|---|
| Schellenberg [21] | Prospective | 20 | 25 | 1 | 30 | 94 | 11.8 |
| Polistina [22] | Prospective | 23 | 30 | 3 | 9 | 57 | 10.6 |
| Chang [23] | Retrospective | 77 | 25 | 1 | 6 | 84 | 11.4 |
| Mahadevan [24] | Retrospective | 39 | 24–36 | 3 | 21 | 85 | 20 |
| Didolkar [25] | Prospective | 85 | 15–30 | 3 | 8 | 91.7 | 18.6 |
| Koong [26] | Prospective | 15 | 15–25 | 1 | - | 77 | 11 |
| Rwigema [27] | Retrospective | 71 | 18–25 | 1 | 12.7 | 64.8 | 10.3 |
| Tozzi [28] | Prospective | 30 | 36–45 | 6 | 11 | 96 | 19.5 |